Alithea Genomics

Epalinges, Switzerland · Founded 2020 · Privately Held (backing)

Developer of cost-efficient transcriptomics designed to perform biomedical discoveries. Alithea Genomics is based in Epalinges, Switzerland and was founded in 2020. Its last reported valuation was $66.4 million in Mar 2026. It has raised $9.1 million.

Last reported valuation
$66.4M
Oct 2026
Priced at
—
Total raised
$9.1M
Last round
—

Who backs Alithea Genomics?

8 investors
InvestorType
Venture KickOther
Ecole Polytechnique Federale de LausanneOther
KickfundVenture capital
Zürcher KantonalbankAsset manager
Biopole—
Genku Ventures—
Novalis Biotech—
TechU Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Alithea Genomics investors

8 investors are on record for Alithea Genomics, including Venture Kick, Ecole Polytechnique Federale de Lausanne, Kickfund and Zürcher Kantonalbank.

Free account
More of Alithea Genomics with a free account
  • ·Watch Alithea Genomics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Alithea Genomics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View